These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2537355)

  • 1. Recognition of HIV glycoprotein gp120 by T cells. Role of monocyte CD4 in the presentation of gp120.
    Siliciano RF; Knall C; Lawton T; Berman P; Gregory T; Reinherz EL
    J Immunol; 1989 Mar; 142(5):1506-11. PubMed ID: 2537355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
    Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of GP120 binding to CD4 and an assay that measures ability of sera to inhibit this binding.
    Schnittman SM; Lane HC; Roth J; Burrows A; Folks TM; Kehrl JH; Koenig S; Berman P; Fauci AS
    J Immunol; 1988 Dec; 141(12):4181-6. PubMed ID: 3264307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
    Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
    J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of CD4 glycoprotein determinant-HIV envelope protein interactions: perspectives for analog and vaccine development.
    Farrar WL; Harel-Bellan A; Ferris DK
    Crit Rev Immunol; 1988; 8(4):315-39. PubMed ID: 2850890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 transmission and function of virus-infected monocytes/macrophages.
    Mann DL; Gartner S; Le Sane F; Buchow H; Popovic M
    J Immunol; 1990 Mar; 144(6):2152-8. PubMed ID: 1690236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV env glycoprotein shares a cross-reacting epitope with a surface protein present on activated human monocytes and involved in antigen presentation.
    Beretta A; Grassi F; Pelagi M; Clivio A; Parravicini C; Giovinazzo G; Andronico F; Lopalco L; Verani P; Buttò S
    Eur J Immunol; 1987 Dec; 17(12):1793-8. PubMed ID: 2446880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
    Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
    J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen targeting to antigen-presenting cells enhances presentation to class II-restricted T lymphocytes.
    Scardino A; Paroli M; De Petrillo G; Michel ML; Barnaba V
    Immunology; 1994 Jan; 81(1):167-70. PubMed ID: 7907575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cells can present antigens such as HIV gp120 targeted to their own surface molecules.
    Lanzavecchia A; Roosnek E; Gregory T; Berman P; Abrignani S
    Nature; 1988 Aug; 334(6182):530-2. PubMed ID: 2841610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 GP120-mediated immune suppression and lymphocyte destruction in the absence of viral infection.
    Weinhold KJ; Lyerly HK; Stanley SD; Austin AA; Matthews TJ; Bolognesi DP
    J Immunol; 1989 May; 142(9):3091-7. PubMed ID: 2468713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion of human B cell lines with HIV-1 envelope-expressing T cells is enhanced by antigen-specific Ig receptors. Possible mechanism for elimination of gp120-specific B cells in vivo.
    Golding H; Dimitrov DS; Blackburn R; Manischewitz J; Blumenthal R; Golding B
    J Immunol; 1993 Mar; 150(6):2506-16. PubMed ID: 7680694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galactose receptors and presentation of HIV envelope glycoprotein to specific human T cells.
    Manca F
    J Immunol; 1992 Apr; 148(7):2278-82. PubMed ID: 1312106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation.
    Wang JM; Ueda H; Howard OM; Grimm MC; Chertov O; Gong X; Gong W; Resau JH; Broder CC; Evans G; Arthur LO; Ruscetti FW; Oppenheim JJ
    J Immunol; 1998 Oct; 161(8):4309-17. PubMed ID: 9780207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor.
    Callahan KM; Fort MM; Obah EA; Reinherz EL; Siliciano RF
    J Immunol; 1990 May; 144(9):3341-6. PubMed ID: 1970352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding.
    Clayton LK; Sieh M; Pious DA; Reinherz EL
    Nature; 1989 Jun; 339(6225):548-51. PubMed ID: 2543930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
    Brett SJ; Rhodes J; Liew FY; Tite JP
    J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
    Xiao X; Kinter A; Broder CC; Dimitrov DS
    Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.
    Hussey RE; Richardson NE; Kowalski M; Brown NR; Chang HC; Siliciano RF; Dorfman T; Walker B; Sodroski J; Reinherz EL
    Nature; 1988 Jan; 331(6151):78-81. PubMed ID: 2829023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of CD4+ T cell function by the HIV envelope protein, gp120.
    Diamond DC; Sleckman BP; Gregory T; Lasky LA; Greenstein JL; Burakoff SJ
    J Immunol; 1988 Dec; 141(11):3715-7. PubMed ID: 2846691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.